Index of reports
> Cases with Renal Failure Acute (12)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to MS Contin (Morphine) where reactions include renal failure acute. The selected reports were submitted to the FDA during the sample period of about a year.
Possible MS Contin side effects in male
Reported by a physician from United States on 2012-08-23
Patient: male, weighing 140.6 kg (309.3 pounds)
Reactions: Myoclonus, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
MS Contin
Dosage: 30 mg, tid
Administration route: Oral
Indication: Pain
Oxycodone HCL
Dosage: 40 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-08-02
End date: 2012-08-09
Other drugs received by patient: Fish OIL; Stool Softener; Potassium; Dulcolax; Amitriptyline Hydrochloride; Omeprazole; Morphine Sulfate; Lasix; Metformin; Neurontin; Simvastatin; Lisinopril; Coumadin; Fenofibrate
Possible MS Contin side effects in 54 year old female
Reported by a physician from United States on 2012-08-13
Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)
Reactions: Vomiting, Nausea, Diarrhoea, Dehydration, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aleve
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-13
Doxycycline HCL
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-20
Motrin
Administration route: Oral
Indication: Pain
Start date: 2011-12-19
End date: 2012-06-11
MS Contin
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-12
Unknown Medication
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-18
Zofran
Indication: Nausea
Start date: 2012-06-17
End date: 2012-06-19
Other drugs received by patient: Vitamin B-12; Ascorbic Acid; Pamidronate Disodium; Vitamine E; Multiple Vitamin; Folic Acid; Vitamin D
Possible MS Contin side effects in 81 year old female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-13
Patient: 81 year old female
Reactions: Renal Failure Acute, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
MS Contin
Dosage: unk
Indication: Pain
Start date: 2012-06-27
End date: 2012-06-30
Oramorph SR
Dosage: 12 drop, daily
Administration route: Oral
Start date: 2012-06-27
End date: 2012-06-30
Other drugs received by patient: Gabapentin; Bisoprolol; Clonazepam; Omeprazole; Femara
Possible MS Contin side effects in 54 year old female
Reported by a physician from United States on 2012-08-08
Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)
Reactions: Diarrhoea, Nausea, Dehydration, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dacomitinib
Dosage: 45 mg, cohorts i and ii daily continous
Start date: 2012-06-26
Dacomitinib
Dosage: 45 mg, cohorts i and ii daily continous
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-18
Doxycycline HCL
Dosage: 100 mg, bid
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-20
MS Contin
Dosage: 15 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-12
Naproxen (Aleve)
Dosage: 220 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-13
Other drugs received by patient: Folic Acid; Vitamin E; Ascorbic Acid; Vitamin B-12; Vitamin D; Pamidronate Disodium; Theragran-M; Motrin
Possible MS Contin side effects in 81 year old female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-03
Patient: 81 year old female
Reactions: Respiratory Depression, Lethargy, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
MS Contin
Dosage: 20 mg, daily
Administration route: Oral
Indication: Pain
Start date: 2011-01-01
End date: 2012-06-19
Oramorph SR
Dosage: 12 gtt, daily
Administration route: Oral
Indication: Pain
Start date: 2012-01-01
End date: 2012-06-19
Other drugs received by patient: Femara; Omeprazole; Bisoprolol Hemifumarate / Hydrochlorothiazide; Ferrofolin; Gabapentin; Rivotril
Possible MS Contin side effects in 81 year old female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-31
Patient: 81 year old female
Reactions: Respiratory Depression, Renal Failure Acute, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
MS Contin
Dosage: 20 mg, daily
Administration route: Oral
Start date: 2012-07-27
MS Contin
Dosage: 20 mg, daily
Administration route: Oral
Indication: Pain
Start date: 2011-01-01
End date: 2012-06-19
Oramorph SR
Dosage: 12 gtt, daily
Administration route: Oral
Start date: 2012-07-27
Oramorph SR
Dosage: 12 gtt, daily
Administration route: Oral
Indication: Pain
Start date: 2012-01-01
End date: 2012-06-19
Other drugs received by patient: Gabapentin; Omeprazole; Bisoprolol Hemifumarate / Hydrochlorothiazide; Ferrofolin; Rivotril; Femara
Possible MS Contin side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-26
Patient: female
Reactions: Respiratory Depression, Renal Failure Acute, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
MS Contin
Dosage: 20 mg, daily
Administration route: Oral
Indication: Pain
Start date: 2011-01-01
End date: 2012-06-19
Oramorph SR
Dosage: 12 drop, daily
Administration route: Oral
Indication: Pain
Start date: 2012-01-01
End date: 2012-06-19
Other drugs received by patient: Bisoprolol Fumarate; Gabapentin; Omeprazole; Femara; Ferrofolin; Clonazepam
Possible MS Contin side effects in 54 year old female
Reported by a physician from United States on 2012-07-17
Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)
Reactions: Vomiting, Diarrhoea, Nausea, Dehydration, Blood Creatine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aleve
Dosage: 220 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-13
Doxycycline
Dosage: 100 mg, bid
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-20
Motrin
Dosage: 800 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2011-12-19
End date: 2012-06-12
MS Contin
Dosage: 15 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-12
Study Drug
Dosage: 45 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-18
Zofran
Dosage: 4 mg, q6h
Indication: Nausea
Start date: 2012-06-17
End date: 2012-06-19
Other drugs received by patient: Theragran-M / 00610701 /; Vitamin D; Folic Acid; B12 / 00056201 /; Vitamin C / 00008001 /; Pamidronate Disodium; Vitamin E / 00110501 /
Possible MS Contin side effects in 54 year old female
Reported by a physician from United States on 2012-07-13
Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)
Reactions: Vomiting, Diarrhoea, Nausea, Dehydration, Blood Creatine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aleve
Dosage: 220 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-13
Doxycycline
Dosage: 100 mg, bid
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-20
Motrin
Dosage: 800 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2011-12-19
End date: 2012-06-12
MS Contin
Dosage: 15 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-12
Study Drug
Dosage: 45 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-18
Zofran
Dosage: 4 mg, q6h
Indication: Nausea
Start date: 2012-06-17
End date: 2012-06-19
Other drugs received by patient: Vitamin D; Theragran-M / 00610701 /; B12 / 00056201 /; Vitamin C / 00008001 /; Vitamin E / 00110501 /; Pamidronate Disodium; Folic Acid
Possible MS Contin side effects in 54 year old female
Reported by a physician from United States on 2012-07-06
Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)
Reactions: Vomiting, Nausea, Diarrhoea, Dehydration, Blood Creatine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aleve
Dosage: 220 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-13
Doxycycline Hyclate
Dosage: 100 mg, bid
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-20
Motrin
Dosage: 800 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2011-12-19
End date: 2012-06-12
MS Contin
Dosage: 15 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-12
Study Drug
Dosage: 45 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-18
Zofran
Dosage: 4 mg, q6h
Indication: Nausea
Start date: 2012-06-17
End date: 2012-06-19
Other drugs received by patient: Pamidronate Disodium; Folic Acid; Theragran-M / 00610701 /; B12 / 00056201 /; Vitamin E / 00110501 /; Vitamin C / 00008001 /; Vitamin D
Possible MS Contin side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-02
Patient: female
Reactions: Pulmonary Hypertension, Biliary Tract Operation, Drug Ineffective, Pancreatic Neoplasm, Death, Hepatic Encephalopathy, Oesophagitis, Cholangitis, Pancreatitis Chronic, Gastrooesophageal Reflux Disease, Renal Failure Acute, Dysphagia, Metabolic Acidosis, Type 2 Diabetes Mellitus, Hypotension, Renal Failure Chronic, Cerebrovascular Accident, Hyperlipidaemia, Diarrhoea, Liver Transplant Rejection, Feeling Abnormal, Hypertension, Herpes Virus Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Lactulose
Dosage: unk
Indication: Product Used FOR Unknown Indication
MS Contin
Dosage: unk
Indication: Pain
Prograf
Dosage: 0.5 unk, q3d
Start date: 2012-01-01
End date: 2012-01-29
Prograf
Dosage: 0.5 mg, bid
Administration route: Oral
Indication: Liver Transplant
Start date: 1997-07-08
End date: 2012-01-01
Other drugs received by patient: Diflucan; Sodium Bicarbonate; Carafate; Morphine; Oxycodone HCL; Xifaxan; MAG-OX; Protonix; Insulin; Creon; Metoprolol Succinate
Possible MS Contin side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-19
Patient: female
Reactions: Pulmonary Hypertension, Biliary Tract Operation, Drug Ineffective, Pancreatic Neoplasm, Death, Hepatic Encephalopathy, Oesophagitis, Cholangitis, Pancreatitis Chronic, Gastrooesophageal Reflux Disease, Renal Failure Acute, Type 2 Diabetes Mellitus, Dysphagia, Metabolic Acidosis, Hypotension, Renal Failure Chronic, Cerebrovascular Accident, Hyperlipidaemia, Diarrhoea, Liver Transplant Rejection, Hypertension, Feeling Abnormal, Herpes Virus Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Lactulose
Dosage: unk
Indication: Product Used FOR Unknown Indication
MS Contin
Dosage: unk
Indication: Pain
Prograf
Dosage: 0.5 unk, q3d
Start date: 2012-01-01
End date: 2012-01-29
Prograf
Dosage: 0.5 mg, bid
Administration route: Oral
Indication: Liver Transplant
Start date: 1997-07-08
End date: 2012-01-01
Other drugs received by patient: Morphine; Oxycodone HCL; Metoprolol Succinate; Creon; Xifaxan; Protonix; Sodium Bicarbonate; Insulin; MAG-OX; Diflucan; Carafate
|